Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese‐exposed non‐human primates
暂无分享,去创建一个
[1] Wei Zheng,et al. Alteration of saliva and serum concentrations of manganese, copper, zinc, cadmium and lead among career welders. , 2008, Toxicology letters.
[2] V. Rotter,et al. Amyloid-β precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress , 2007, Oncogene.
[3] M. Walsh. The global experience with lead in gasoline and the lessons we should apply to the use of MMT. , 2007, American journal of industrial medicine.
[4] M. Panisset,et al. Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years. , 2007, American journal of industrial medicine.
[5] Roberto G Lucchini,et al. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. , 2007, American journal of industrial medicine.
[6] Susan M. Resnick,et al. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons , 2007, Neurobiology of Aging.
[7] D. Perl,et al. The Neuropathology of Manganese-Induced Parkinsonism , 2007, Journal of neuropathology and experimental neurology.
[8] P. Pasqualetti,et al. [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution]. , 2007, Giornale italiano di medicina del lavoro ed ergonomia.
[9] J. Bergquist,et al. Irreversible motor impairment in young addicts – ephedrone, manganism or both? , 2007, Acta neurologica Scandinavica.
[10] T. Guilarte,et al. Manganese: recent advances in understanding its transport and neurotoxicity. , 2007, Toxicology and applied pharmacology.
[11] H. Cheong,et al. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings. , 2007, Neurotoxicology.
[12] Hasan Meral,et al. Parkinsonism Caused by Chronic Usage of Intravenous Potassium Permanganate , 2007, The neurologist.
[13] M. Burritt,et al. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity , 2006, Neurology.
[14] T. Guilarte,et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.
[15] T. Guilarte,et al. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[16] T. Guilarte,et al. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates , 2006, Brain Research.
[17] R. Bowler,et al. Dose–effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders , 2006, Occupational and Environmental Medicine.
[18] P. Brandt-Rauf,et al. A Novel Mechanism for p53 to Regulate Its Target Gene ECK in Signaling Apoptosis , 2006, Molecular Cancer Research.
[19] N. Kumar,et al. Neuropsychological profiles of manganese neurotoxicity , 2006, European journal of neurology.
[20] John Calvin Reed,et al. Regulation of p53 Localization and Activity by Ubc13 , 2006, Molecular and Cellular Biology.
[21] Carlos Santos-Burgoa,et al. Motor alterations associated with exposure to manganese in the environment in Mexico. , 2006, The Science of the total environment.
[22] I. Ferrer,et al. Interlaboratory Comparison of Assessments of Alzheimer Disease-Related Lesions: A Study of the BrainNet Europe Consortium , 2006, Journal of neuropathology and experimental neurology.
[23] B. Lai,et al. Metal exposure and Alzheimer's pathogenesis. , 2006, Journal of structural biology.
[24] I. Lascu,et al. DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells , 2006, Journal of cellular biochemistry.
[25] Sanae Nakagawa,et al. Manganese exposure: neuropsychological and neurological symptoms and effects in welders. , 2006, Neurotoxicology.
[26] M. Norenberg,et al. Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment , 2006, Neuroscience Letters.
[27] Christian Haass,et al. Amyloid Precursor-like Protein 1 Influences Endocytosis and Proteolytic Processing of the Amyloid Precursor Protein* , 2006, Journal of Biological Chemistry.
[28] S. Czasch,et al. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain , 2006, Neurobiology of Aging.
[29] W. Deppert,et al. Transcription-independent pro-apoptotic functions of p53. , 2005, Current opinion in cell biology.
[30] M. Trenerry,et al. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity , 2005, Neurology.
[31] C. Culmsee,et al. p53 in neuronal apoptosis. , 2005, Biochemical and biophysical research communications.
[32] F. Ono,et al. Age‐related changes of intracellular Aβ in cynomolgus monkey brains , 2005, Neuropathology and applied neurobiology.
[33] M. Kitazawa,et al. Protein Kinase Cδ Is a Key Downstream Mediator of Manganese-Induced Apoptosis in Dopaminergic Neuronal Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.
[34] K. Becker,et al. National Institute on Aging microarray facility--resources for gerontology research. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[35] Zhongqi Cheng,et al. Water Manganese Exposure and Children’s Intellectual Function in Araihazar, Bangladesh , 2004, Environmental health perspectives.
[36] Hiroshi Murakami,et al. Negative Regulation of Chk2 Expression by p53 Is Dependent on the CCAAT-binding Transcription Factor NF-Y* , 2004, Journal of Biological Chemistry.
[37] Y. Thomassen,et al. Neuropsychological function in manganese alloy plant workers , 2004, International archives of occupational and environmental health.
[38] T. Südhof,et al. Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1* , 2004, Journal of Biological Chemistry.
[39] Stephen C Bondy,et al. Oxidative Basis of Manganese Neurotoxicity , 2004, Annals of the New York Academy of Sciences.
[40] J. Marx. Possible Role for Environmental Copper in Alzheimer's Disease , 2003, Science.
[41] Donna Mergler,et al. Manganese, monoamine metabolite levels at birth, and child psychomotor development. , 2003, Neurotoxicology.
[42] J. Kaiser. Manganese: A High-Octane Dispute , 2003, Science.
[43] K. Becker,et al. Analysis of microarray data using Z score transformation. , 2003, The Journal of molecular diagnostics : JMD.
[44] M. Kubota,et al. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition , 2003, Pediatric Surgery International.
[45] Karl Herrup,et al. Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease , 2003, The Journal of Neuroscience.
[46] Ashley I. Bush,et al. The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.
[47] Barry S. Levy,et al. Neurologic Effects of Manganese in Humans: A Review , 2003, International journal of occupational and environmental health.
[48] Christophe Romier,et al. The NF-YB/NF-YC Structure Gives Insight into DNA Binding and Transcription Regulation by CCAAT Factor NF-Y* , 2003, The Journal of Biological Chemistry.
[49] Y. Hirata. Manganese-induced apoptosis in PC12 cells. , 2002, Neurotoxicology and teratology.
[50] D. Bredesen,et al. Caspase cleavage of members of the amyloid precursor family of proteins , 2002, Journal of neurochemistry.
[51] Y. Sasaki,et al. Identification of the Osteopontin gene as a direct target of TP53 , 2002, Genes, chromosomes & cancer.
[52] Yaolin Wang,et al. Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches* 210 , 2001, The Journal of Biological Chemistry.
[53] F. Checler,et al. The caspase‐derived C‐terminal fragment of βAPP induces caspase‐independent toxicity and triggers selective increase of Aβ42 in mammalian cells , 2001, Journal of neurochemistry.
[54] C. Pozniak,et al. Neuronal life and death: an essential role for the p53 family , 2000, Cell Death and Differentiation.
[55] Y. Kinoshita,et al. The role of p53 in neuronal cell death , 2000, Cell Death and Differentiation.
[56] Xiongwei Zhu,et al. Cyclin' toward dementia , 2000, Journal of neuroscience research.
[57] S. Chandra,et al. A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor , 2000, Nature Medicine.
[58] J. Gitlin,et al. The Role of Copper in Neurodegenerative Disease , 1999, Neurobiology of Disease.
[59] T. Hashimoto,et al. Tremor and seizures associated with chronic manganese intoxication , 1999, Brain and Development.
[60] B. Hyman,et al. Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains , 1998, Brain Research.
[61] M. Mesulam,et al. Infracortical interstitial cells concurrently expressing m2-muscarinic receptors, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate-diaphorase in the human and monkey cerebral cortex , 1998, Neuroscience.
[62] Sascha Weggen,et al. Amyloid precursor-like protein 1 accumulates in neuritic plaques in Alzheimer’s disease , 1997, Acta Neuropathologica.
[63] X. Chen,et al. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner , 1997, Molecular and cellular biology.
[64] J. Wands,et al. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease , 1997, Journal of the Neurological Sciences.
[65] A. Levine,et al. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro , 1997, Molecular and cellular biology.
[66] F. LaFerla,et al. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. , 1996, The Journal of clinical investigation.
[67] I. Black,et al. Characterization of the genomic structure of the mouse APLP1 gene. , 1996, Genomics.
[68] T. Shin,et al. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53 , 1995, Molecular and cellular biology.
[69] I. Black,et al. Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density. , 1995, Brain research. Molecular brain research.
[70] M. Beal,et al. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: Normal anatomy and alterations in alzheimer's disease , 1988, Annals of neurology.
[71] A. Mathee,et al. Blood manganese concentrations among first-grade schoolchildren in two South African cities. , 2005, Environmental research.
[72] M. Evans,et al. p53 modulation of TFIIH–associated nucleotide excision repair activity , 1995, Nature Genetics.